![]() |
Sign Up! | Tags | Domains | Statistics | Options | Advanced Search |
Tagged: conference news, mexico 2008, new drugs news, side effects news, pharmacokinetics news
A new 100 mg tablet formulation of the protease inhibitor ritonavir (Norvir) appears to be equivalent to the current soft-gel capsule formulation in terms of side-effects and boosting potential, according to data presented to the XVII International AIDS Conference in Mexico City last week. The new tablet formulation, which like the Kaletra tablet, is heat-stable and does not require … Continue Reading »